 CAMBRIDGE, Mass., March 02, 2022 GLOBE NEWSWIRE -- Mersana Therapeutics, Inc., NASDAQ: MRSN a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ADCs targeting cancers in areas of high unmet medical need, today announced that the Company will participate in a virtual panel presentation at the Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022 at 12:50 p.m. ET. 